972 resultados para GAMMA-GLOBIN GENE
Resumo:
The Human Papillomavirus (HPV) belongs to the Papillomaviridae family and has a capsid and a single DNA strand. Its infection occurs mainly through sexual intercourse, having an important tropism for skin and mucosal cells. Aim: To evaluate the HPV presence in normal oral mucosa of asymptomatic subjects and; in parallel, to correlate social behavioral habits with the virus. Materials and Methods: Contemporary cohort cross-sectional study. The HPV was found by PCR, using general primers MY09/11 in 125 oral mucosa samples submitted to DNA extraction and PCR to search for the beta-globin gene in order to assess the quality of the extracted DNA. In parallel, we carried out a study of behavioral issues associated with the patients. Results: All the samples had a positive diagnosis of the beta-hemoglobin gene. HPV was diagnosed in 23.2% of the samples analyzed. Conclusion: The virus was present in 29 of the 125 patients, without them having any clinical-pathological manifestation associated with the HPV. As to the social behavior of the patients, we concluded that oral sex is statistically correlated to the virus, and besides the HPV has been statistically more present in female patients.
Resumo:
Zusammenfassung In der vorliegenden Arbeit wurden 74736 bp genomischer DNA-Sequenzder Hämoglobingen-Gruppe D aus der Chironomiden Art Chironomus tentansentschlüsselt und analysiert. Durch Datenbankrecherchen undSequenz-Vergleiche wurden 29 vollständige Hämoglobin-Geneidentifiziert und klassifiziert. Es zeigt sich, daß alle derzeitbekannten Hämoglobin-Gene der Chironomiden auch in Chironomus tentansvorhanden sind. Zusätzlich konnten in Chironomus tentans sechs neueHämoglobin-Varianten identifiziert werden, die bislang weder aufProtein- noch auf Gen-Ebene in anderen Spezies nachgewiesenwurden. Die Hämoglobin-Gene liegen in dichter Abfolge innerhalbdes Clusters, wobei durchschnittlich etwa alle 2 kb ein Gen zufinden ist. Die Abfolge der Hämoglobin-Gene innerhalb derGengruppe wird nur an einer Stelle durch ein interspergiertes Genaus der Familie der Glukosetransporter unterbrochen. Desweiterenkonnten zwei retrotransponierbare Elemente der SINE-Klasse (CP1)innerhalb des Hämoglobingen-Clusters identifiziert werden. AlleGene besitzen die für ihre Expression erforderlichenSignalsequenzen, so daß es sich höchstwahrscheinlich um aktiveGene handelt. Die abgeleiteten Aminosäure-Sequenzen weisen alleCharakteristika sauerstofftransportierender Moleküle auf. Da es sich bei den Hämoglobinen um eine sehr alte Genfamiliehandelt, kann die vergleichende Analyse derHämoglobin-Genstruktur bei Vertebraten, Invertebraten, Pflanzenund Protozoen zur Rekonstruktion der Intron-Evolution genutztwerden. Die Konservierung von Intronpositionen in homologen Genenverschiedener Taxa gilt dabei als Maß für das relativestammesgeschichtliche Alter der Introns. Eine Vielzahl derHämoglobin-Gene von Invertebraten weisen ein Intron im zentralenGenbereich auf. Auch bei einigen Chironomiden-Arten konntendiese 'zentralen Introns' nachgewiesen werden. DieHämoglobin-Gene von Chironomus tentans galten hingegen bislang als intronlos.Die vorliegende Untersuchung zeigt, daß auch zweiHämoglobin-Gene dieser Spezies je ein kurzes Intron aufweisen.Der Vergleich der Intronverteilung in den Hämoglobin-Genen derChironomiden führt zu dem Ergebnis, daß alle vorhandenen Intronsam sparsamsten (im Sinne des 'maximum parsimony'-Prinzips) durchunabhängige Insertionen in ein intronlosesVorläufer-Hämoglobin-Gen erklärt werden können. Alle bislangin Chironomiden beschriebenen Introns sind mit großerWahrscheinlichkeit nicht ortholog (Hankeln et al., 1997; dieseArbeit). Das Vorläufer-Hämoglobin-Gen in Chironomiden besaßdaher vermutlich kein 'zentrales Intron'. Die in Chironomidengefundenen Verhältnisse stellen somit die von Go (1981)formulierte Hypothese der Ursprünglichkeit des 'zentralenIntrons' in Hämoglobin-Genen in Frage. Die in Invertebraten undPflanzen beschriebenen 'zentralen Introns' sind vermutlich nichthomolog und dementsprechend auch nicht auf ein Intron imanzestralen Globin zurückzuführen. Vielmehr implizieren die inhohem Maße variablen Positionen der 'zentralen Introns' beiPflanzen und Invertebraten ihre unabhängige Insertion in diejeweiligen Globin-Gene nach der Aufspaltung der Taxa. Grundsätzlich können zwei Klassen von Hämoglobin-Genen inChironomiden unterschieden werden. Die überwiegende Mehrzahl derHämoglobine wird von Genen kodiert, die nur in einer Kopie imGenom vorliegen. Sie werden dementsprechend als 'single copy'Varianten bezeichnet. Für andere Hämoglobin-Varianten konntehingegen eine Vielzahl leicht unterschiedlicher Gene beschriebenwerden. Diese bilden sogenannte Gen-Subfamilien. In Chironomus tentans konntegezeigt werden, daß neben den 7B-Genen auch die 7A-Gene eineeigene Subfamilie bilden. Die 'single copy' Varianten zeichnensich im Interspezies-Vergleich durch ihre konservierteNukleotid-Sequenz aus: Sie unterliegen während ihrer Evolutionoffenbar einer stabilisierenden Selektion, d.h. Veränderungenihrer Protein-Sequenzen werden nur in geringem Maße toleriert.Auch ihre räumliche Anordnung innerhalb der Gengruppe istzwischenartlich konserviert. Der Vergleich der 'single copy'Varianten innerhalb einer Art zeigt, daß diese sehr deutlicheSequenz-Unterschiede zueinander aufweisen. Sie bilden somit einkonserviertes Sortiment an Hämoglobin-Genen, das weitgehend vorder Radiation der Arten entstanden ist und eine über dieArtgrenzen hinweg unveränderte 'Hämoglobin-Grundausstattung'gewährleistet. Im Gegensatz hierzu zeichnen sich die Mitglieder vonHämoglobin-Gen-Sub-familien durch eine hohe Variabilität aus:Nukleotid-Sequenz, Anzahl und Organisation der Gene innerhalb derGenfamilie weisen im zwischenartlichen Vergleich zahlreicheUnterschiede auf. Es ist daher nur selten möglich allein aufGrundlage der Nukleotid-Sequenzen orthologe Genpaare zuidentifizieren. Die orthologen Gene der 7B-Subfamilie aus Chironomus tentansund chth konnten ausschließlich anhand korrespondierenderIntergen-Sequenzen einander zugeordnet werden. Somit sind dieGen-Subfamilien präferenziell an der Entstehung einesspeziesspezifischen Gen-Repertoires beteiligt. Variationen derNukleotid-Sequenz, Gen-Anzahl und Gen-Organisation innerhalb derSubfamilie werden im Gegensatz zu den 'single copy' Varianten ineinem hohen Maße toleriert. Aufgrund der hohen Sequenz-Übereinstimmungen zwischen denMitgliedern der Gen-Subfamilien unterliegen diese einer Vielzahlvon Rearrangements, die in Gen-Duplikationen, Deletionen undSequenz-Homogenisierungen resultieren. So führten beispielsweiseGenduplikationen durch ungleiches, homologes Crossing-over mitgroßer Wahrscheinlichkeit zur Entstehung und Expansion der7A-Subfamilie. Auch die Gene Cte12-1 und Cte 12-2 sind vermutlichdas Ergebnis eines rezenten Duplika-tions-Ereignisses. DerMechanismus der Retrotransposition, der zu einer Duplika-tioneines 3`-untranslatierten Bereichs innerhalb der 7A-Subfamilieführte, scheint für die Entstehung derHämoglobin-Multiplizität in Chironomiden hingegen wenigerbedeutsam zu sein. Innerhalb der 7A-Subfamilie ist eineAngleichung der Gene durch konzertierte Sequenz-Evolution zubeobachten. Der nukleotidweise Vergleich von Gen-Sequenzen zeigtam Beispiel der Gene 7A7 und 7A8, daß die konzertierte Evolutiondieser Gen-Varianten auf dem Mechanismus der Genkonversionberuht. Auch die Gen-Subfamilie 7B unterliegt offenbar in hohemMaße einer solchen Sequenz-Homogenisierung. Im Sinne einer molekularen Uhr sollten synonyme Basenaustauscheweitgehend neutral sein und sich proportional zur Zeit in denGenen anhäufen. Der Vergleich der Hämoglobin-Gen-Sequenzenzeigt, daß große Unterschiede in der Anzahl der synonymenBasenaustausche zwischen orthologen Genen nicht zwangsläufig dasErgebnis einer frühen Trennung dieser Gene sind. Die Übertragungvon Sequenzen zwischen paralogen Genen kann die Anzahl dersynonymen Basenaustausche orthologer Gene in kürzester Zeitverändern und den tatsächlichen Zeitpunkt der Trennung zweierorthologen Gene überdecken. Werden Genkonversionen nichterkannt, weil beispielsweise nicht alle Gene der Gruppevollständig erfaßt werden konnten, führt der Vergleichorthologer Gen-Sequenzen zwangsläufig zu falschen evolutionärenGendistanzen. Da die Mitglieder der Hämoglobin-Genfamiliebesonders häufig Rekombinations-Prozessen unterliegen, sind siedaher möglicherweise weniger nützliche Kanditaten für dieErmittlung evolutionärer Distanzen zwischen den verschiedenenChironomiden-Arten. Insgesamt zeigen die Ergebnisse dieser Arbeit, daß anhanddetaillierter phylogenetischer Analysen sich die Evolution derHämoglobin-Multigenfamilie von Chironomiden umfassendbeschreiben läßt. Ob einzelne, besonders gut konservierteGen-Varianten (wie z. B. die Gene Cte 8 und Cte W) einespezifische physiologische Funktion erfüllen oder ob dieGen-Subfamilien, die ein speziesspezifisches Genrepertoirebilden, an der Einnischung der verschiedenen Arten beteiligtsind, sollte durch weiterführende Untersuchungen (z. B. derGenexpression sowie der physiologischen Eigenschaften einzelnerVarianten) ermittelt werden können.
Resumo:
Hypoxie ist ein Zustand des Sauerstoffmangels, hervorgerufen durch fehlende Verfügbarkeit von Sauerstoff in der Umgebung eines Organismus oder durch pathologisch bedingte unzureichende Nutzbarkeit des Sauerstoffs von Geweben. Die Sensitivität gegenüber Hypoxie variiert enorm im Tierreich zwischen verschiedenen Phyla und Spezies. Die meisten Säugetiere sind nur unzureichend an niedrige Sauerstoffkonzentrationen angepasst, wohingegen einige unterirdisch lebende Säuger sehr resistent gegen Hypoxiestress sind. Um die molekulare Basis der Hypoxietoleranz zu bestimmen, wurden in der vorliegenden Arbeit Globine untersucht, die potenziell in der Lage sind, als respiratorische Proteine zur Hypoxietoleranz von Tieren beizutragen. Dazu wurde die Expression der Globine in der hypoxieresistenten, in Israel lebenden Blindmaus Spalax ehrenbergi mit der Genexpression in der hypoxiesensitiven Ratte (Rattus norvegicus) verglichen. In der vorliegenden Arbeit wurden die erst vor wenigen Jahren entdeckten Globine Neuroglobin und Cytoglobin untersucht, deren exakte physiologische Rolle noch unklar ist, und mit Daten des viel detaillierter untersuchten Myoglobins verglichen. Beim Vergleich der Expression von Cytoglobin und Neuroglobin in Spalax versus Ratte fällt auf, dass Neuroglobin und Cytoglobin bereits unter normoxischen Bedingungen auf mRNA- und Proteinebene in der Blindmaus um einen Faktor von mindesten 2 bis 3 verstärkt exprimiert werden. Bei Myoglobin (als dem Kontrollgen mit bekannter Funktion) konnte auf mRNA-Ebene eine noch weitaus stärkere Expression in Spalax vs. Ratte gefunden werden. Das übergreifende Phänomen der verstärkten Genexpression von Globinen in Spalax kann im Sinne einer Präadaptation an das unterirdische, häufig hypoxische Leben der Blindmaus interpretiert werden. Einen weiteren Hinweis auf eine besondere, spezialisierte Funktion von Neuroglobin in Spalax geben immunhistochemische Daten, die zeigen, dass Neuroglobin im Gehirn von Spalax im Gegensatz zur Ratte nicht nur in Neuronen, sondern auch in Gliazellen exprimiert wird. Dies impliziert Änderungen des oxidativen Stoffwechsels im Nervensystem der hypoxietoleranten Spezies. Die zellulären Expressionsmuster von Cytoglobin erscheinen hingegen in beiden Säugerspezies weitgehend identisch. Es wurde der Frage nachgegangen, ob und wie experimentell induzierte Hypoxie die Genexpression der Globine verändert. Dabei zeigten sich für Neuroglobin und Cytoglobin unterschiedliche Expressionsmuster. Neuroglobin wird unter diversen Sauerstoffmangelbedingungen sowohl in der Ratte als auch in Spalax auf mRNA- und Proteinebene herunterreguliert. Ein ähnliches Regulationsverhalten wurde auch für Myoglobin beobachtet. Die verminderte Expression von Neuroglobin (und evtl. auch Myoglobin) unter Hypoxie ist mit einer gezielten Verringerung der Sauerstoff-Speicherkapazität in Abwesenheit von O2 zu erklären. Ein weiterer denkbarer Grund könnte auch die allgemeine Tendenz sein, unter Hypoxie aus Energiespargründen den Metabolismus herunter zu regulieren. Cytoglobin, das bei normalen Sauerstoffbedingungen nur im Gehirn von Spalax (nicht jedoch in Herz und Leber) ebenfalls um Faktor 2 bis 3 stärker exprimiert wird als in der Ratte, ist mit einiger Sicherheit ebenfalls von adaptivem Nutzen für die Anpassung von Spalax an niedrige Sauerstoffbedingungen, wenngleich seine Funktion unklar bleibt. Unter Hypoxie wird die Cytoglobin-mRNA sowohl in Spalax als auch in der Ratte hochreguliert. Es konnte in der vorliegenden Arbeit dargelegt werden, dass die Expression von Cygb höchstwahrscheinlich durch den Transkriptionsfaktor Hif-1 gesteuert wird, der die molekulare Hypoxieantwort vieler Tierarten zentral steuert. In der vorliegenden Arbeit wurde ebenfalls die Expression von Ngb und Cygb im Gehirn des Hausschweins (Sus scrofa) untersucht. Diese Spezies diente in der Arbeit als weiterer hypoxiesensitiver Organismus sowie als biomedizinisch relevantes Modell für eine Operation an Säuglingen mit angeborenen Herzkrankheiten. Die Versuche haben gezeigt, dass die Gabe bestimmter Medikamente wie dem Immunsuppressivum FK506 zu einer erhöhten Ngb-Konzentration auf mRNA-Ebene führen kann, was potenziell im Zusammenhang mit beobachteten protektiven Effekten der Medikamentengabe während und nach der Herzoperation steht.
Resumo:
Tricyclo (tc)-DNA belongs to the class of conformationally constrained DNA analogs that show enhanced binding properties to DNA and RNA. We prepared tc-oligonucleotides up to 17 nt in length, and evaluated their binding efficiency and selectivity towards complementary RNA, their biological stability in serum, their RNase H inducing potential and their antisense activity in a cellular assay. Relative to RNA or 2'-O-Me-phosphorothioate (PS)-RNA, fully modified tc-oligodeoxynucleotides, 10-17 nt in length, show enhanced selectivity and enhanced thermal stability by approximately 1 degrees C/modification in binding to RNA targets. Tricyclodeoxyoligonucleotides are completely stable in heat-deactivated fetal calf serum at 37 degree C. Moreover, tc-DNA-RNA duplexes are not substrates for RNase H. To test for antisense effects in vivo, we used HeLa cell lines stably expressing the human beta-globin gene with two different point mutations in the second intron. These mutations lead to the inclusion of an aberrant exon in beta-globin mRNA. Lipofectamine-mediated delivery of a 17mer tc-oligodeoxynucleotide complementary to the 3'-cryptic splice site results in correction of aberrant splicing already at nanomolar concentrations with up to 100-fold enhanced efficiency relative to a 2'-O-Me-PS-RNA oligonucleotide of the same length and sequence. In contrast to 2'-O-Me-PS-RNA, tc-DNA shows antisense activity even in the absence of lipofectamine, albeit only at much higher oligonucleotide concentrations.
Resumo:
We have used three beta-thalassemic mutations, IVS2-654, -705 and -745, that create aberrant 5' splice sites (5' ss) and activate a common cryptic 3' ss further upstream in intron 2 of the human beta-globin gene to optimize a generally applicable exon-skipping strategy using antisense derivatives of U7 small nuclear RNA (snRNA). Introducing a modified U7 snRNA gene carrying an antisense sequence against the cryptic 3' ss into cultured cells expressing the mutant beta-globin genes, restored correct beta-globin mRNA splicing for all three mutations, but the efficiency was much weaker for IVS2-654 than for the other mutations. The length of antisense sequence influenced the efficiency with an optimum of approximately 24 nucleotides. Combining two antisense sequences directed against different target sites in intron 2, either on separate antisense RNAs or, even better, on a single U7 snRNA, significantly enhanced the efficiency of splicing correction. One double-target U7 RNA was expressed on stable transformation resulting in permanent and efficient suppression of the IVS2-654 mutation and production of beta-globin. These results suggest that forcing the aberrant exon into a looped secondary structure may strongly promote its exclusion from the mRNA and that this approach may be used generally to induce exon skipping.
Resumo:
In several forms of beta-thalassemia, mutations in the second intron of the beta-globin gene create aberrant 5' splice sites and activate a common cryptic 3' splice site upstream. As a result, the thalassemic beta-globin pre-mRNAs are spliced almost exclusively via the aberrant splice sites leading to a deficiency of correctly spliced beta-globin mRNA and, consequently, beta-globin. We have designed a series of vectors that express modified U7 snRNAs containing sequences antisense to either the aberrant 5' or 3' splice sites in the IVS2-705 thalassemic pre-mRNA. Transient expression of modified U7 snRNAs in a HeLa cell line stably expressing the IVS2-705 beta-globin gene restored up to 65% of correct splicing in a sequence-specific and dose-dependent manner. Cell lines that stably coexpressed IVS2-705 pre-mRNA and appropriately modified U7 snRNA exhibited up to 55% of permanent restoration of correct splicing and expression of full-length beta-globin protein. This novel approach provides a potential alternative to gene replacement therapies.
Resumo:
Cell signaling by nitric oxide (NO) through soluble guanylyl cyclase (sGC) and cGMP production regulates physiological responses such as smooth muscle relaxation, neurotransmission, and cell growth and differentiation. Although the NO receptor, sGC, has been studied extensively at the protein level, information on regulation of the sGC genes remains elusive. In order to understand the molecular mechanisms involved at the level of gene expression, cDNA and genomic fragments of the murine sGCα1 subunit gene were obtained through library screenings. Using the acquired clones, the sGCα 1 gene structure was determined following primer extension, 3 ′RACE and intron/exon boundary analyses. The basal activity of several 5′-flanking regions (putative promoter regions) for both the α1 and β1 sGC subunits were determined following their transfection into mouse N1E-115 neuroblastoma and rat RENE1Δ14 uterine epithelial cells using a luciferase reporter plasmid. Using the sGC sequences, real-time RT-PCR assays were designed to measure mRNA levels of the sGC α1 and β1 genes in rat, mouse and human. Subsequent studies found that uterine sGC mRNA and protein levels decreased rapidly in response to 17β-estradiol (estrogen) in an in vivo rat model. As early as 1 hour following treatment, mRNA levels of both sGC mRNAs decreased, and reached their lowest level of expression after 3 hours. This in vivo response was completely blocked by the pure estrogen receptor antagonist, ICI 182,780, was not seen in several other tissues examined, did not occur in response to other steroid hormones, and was due to a post-transcriptional mechanism. Additional studies ex vivo and in various cell culture models suggested that the estrogen-mediated decreased sGC mRNA expression did not require signals from other tissues, but may require cell communication or paracrine factors between different cell types within the uterus. Using chemical inhibitors and molecular targeting in other related studies, it was revealed that c-Jun-N-terminal kinase (JNK) signaling was responsible for decreased sGC mRNA expression in rat PC12 and RFL-6 cells, two models previously determined to exhibit rapid decreased sGC mRNA expression in response to different stimuli. To further investigate the post-transcriptional gene regulation, the full length sGCα1 3′-untranslated region (3′UTR) was cloned from rat uterine tissue and ligated downstream of the rabbit β-globin gene and expressed as a chimeric mRNA in the rat PC12 and RFL-6 cell models. Expression studies with the chimeric mRNA showed that the sGCα 1 3′UTR was not sufficient to mediate the post-transcriptional regulation of its mRNA by JNK or cAMP signaling in PC12 and RFL-6 cells. This study has provided numerous valuable tools for future studies involving the molecular regulation of the sGC genes. Importantly, the present results identified a novel paradigm and a previously unknown signaling pathway for sGC mRNA regulation that could potentially be exploited to treat diseases such as uterine cancers, neuronal disorders, hypertension or various inflammatory conditions. ^
Resumo:
Ancient septicemic plague epidemics were reported to have killed millions of people for 2 millenniums. However, confident diagnosis of ancient septicemia solely on the basis of historical clinical observations is not possible. The lack of suitable infected material has prevented direct demonstration of ancient septicemia; thus, the history of most infections such as plague remains hypothetical. The durability of dental pulp, together with its natural sterility, makes it a suitable material on which to base such research. We hypothesized that it would be a lasting refuge for Yersinia pestis, the plague agent. DNA extracts were made from the dental pulp of 12 unerupted teeth extracted from skeletons excavated from 16th and 18th century French graves of persons thought to have died of plague (“plague teeth”) and from 7 ancient negative control teeth. PCRs incorporating ancient DNA extracts and primers specific for the human β-globin gene demonstrated the absence of inhibitors in these preparations. The incorporation of primers specific for Y. pestis rpoB (the RNA polymerase β-subunit-encoding gene) and the recognized virulence-associated pla (the plasminogen activator-encoding gene) repeatedly yielded products that had a nucleotide sequence indistinguishable from that of modern day isolates of the bacterium. The specific pla sequence was obtained from 6 of 12 plague skeleton teeth but 0 of 7 negative controls (P < 0.034, Fisher exact test). A nucleic acid-based confirmation of ancient plague was achieved for historically identified victims, and we have confirmed the presence of the disease at the end of 16th century in France. Dental pulp is an attractive target in the quest to determine the etiology of septicemic illnesses detected in ancient corpses. Molecular techniques could be applied to this material to resolve historical outbreaks.
Resumo:
Somatic-cell hybrids have been shown to maintain the correct epigenetic chromatin states to study developmental globin gene expression as well as gene expression on the active and inactive X chromosomes. This suggests the potential use of somatic-cell hybrids containing either a maternal or a paternal human chromosome as a model system to study known imprinted genes and to identify as-yet-unknown imprinted genes. Testing gene expression by using reverse transcription followed by PCR, we show that functional imprints are maintained at four previously characterized 15q11–q13 loci in hybrids containing a single human chromosome 15 and at two chromosome 11p15 loci in hybrids containing a single chromosome 11. In contrast, three γ-aminobutyric acid type A receptor subunit genes in 15q12–q13 are nonimprinted. Furthermore, we have found that differential DNA methylation imprints at the SNRPN promoter and at a CpG island in 11p15 are also maintained in somatic-cell hybrids. Somatic-cell hybrids therefore are a valid and powerful system for studying known imprinted genes as well as for rapidly identifying new imprinted genes.
Resumo:
The X chromosome-linked transcription factor GATA-1 is expressed specifically in erythroid, mast, megakaryocyte, and eosinophil lineages, as well as in hematopoietic progenitors. Prior studies revealed that gene-disrupted GATA-1- embryonic stem cells give rise to adult (or definitive) erythroid precursors arrested at the proerythroblast stage in vitro and fail to contribute to adult red blood cells in chimeric mice but did not clarify a role in embryonic (or yolk sac derived) erythroid cells. To examine the consequences of GATA-1 loss on embryonic erythropoiesis in vivo, we inactivated the GATA-1 locus in embryonic stem cells by gene targeting and transmitted the mutated allele through the mouse germ line. Male GATA-1- embryos die between embryonic day 10.5 and 11.5 (E10.5-E11.5) of gestation. At E9.5, GATA-1- embryos exhibit extreme pallor yet contain embryonic erythroid cells arrested at an early proerythroblast-like stage of their development. Embryos stain weakly with benzidine reagent, and yolk sac cells express globin RNAs, indicating globin gene activation in the absence of GATA-1. Female heterozygotes (GATA-1+/-) are born pale due to random inactivation of the X chromosome bearing the normal allele. However, these mice recover during the neonatal period, presumably as a result of in vivo selection for progenitors able to express GATA-1. Our findings conclusively establish the essential role for GATA-1 in erythropoiesis within the context of the intact developing mouse and further demonstrate that the block to cellular maturation is similar in GATA-1- embryonic and definitive erythroid precursors. Moreover, the recovery of GATA-1+/- mice from anemia seen at birth provides evidence indicating a role for GATA-1 at the hematopoietic progenitor cell level.
Resumo:
Few promoters are active at high levels in all cells. Of these, the majority encode structural RNAs transcribed by RNA polymerases I or III and are not accessible for the expression of proteins. An exception are the small nuclear RNAs (snRNAs) transcribed by RNA polymerase II. Although snRNA biosynthesis is unique and thought not to be compatible with synthesis of functional mRNA, we have tested these promoters for their ability to express functional mRNAs. We have used the murine U1a and U1b snRNA gene promoters to express the Escherichia coli lacZ gene and the human alpha-globin gene from either episomal or integrated templates by transfection, or infection into a variety of mammalian cell types. Equivalent expression of beta-galactosidase was obtained from < 250 nucleotides of 5'-flanking sequence containing the complete promoter of either U1 snRNA gene or from the 750-nt cytomegalovirus promoter and enhancer regions. The mRNA was accurately initiated at the U1 start site, efficiently spliced and polyadenylylated, and localized to polyribosomes. Recombinant adenovirus containing the U1b-lacZ chimeric gene transduced and expressed beta-galactosidase efficiently in human 293 cells and airway epithelial cells in culture. Viral vectors containing U1 snRNA promoters may be an attractive alternative to vectors containing viral promoters for persistent high-level expression of therapeutic genes or proteins.
Resumo:
Hemochromatosis (HC) is an inherited disorder of iron absorption, mapping within the human major histocompatibility complex (MHC). We have identified a multigene system in the murine MHC that contains excellent candidates for the murine equivalent of the human HC locus and implicate nonclassical class I genes in the control of iron absorption. This gene system is characterized by multiple copies of two head-to-head genes encoded on opposite strands and driven by one common regulatory motif. This regulatory motif has a striking homology to the promoter region of the beta-globin gene, a gene obviously involved in iron metabolism and hence termed beta-globin analogous promoter (betaGAP). Upstream of the betaGAP sequence are nonclassical class I genes. At least one of these nonclassical class I genes, Q2, is expressed in the gastrointestinal tract, the primary site of iron absorption. Also expressed in the gastrointestinal tract and downstream of the betaGAP motif is a second set of putative genes, termed Hephaestus (HEPH). Based on these observations, we hypothesized that the genes that seem to be controlled by the betaGAP regulatory motifs would be responsible for the control of Fe absorption. As a test of this hypothesis, we predicted that mice which have altered expression of class I gene products, the beta2-microglobulin knockout mice, [beta2m(-/-)], would develop Fe overload. This prediction was confirmed, and these results indicate beta2m-associated proteins are involved in the control of intestinal Fe absorption.
Resumo:
Fusion phage libraries expressing single-chain Fv antibodies were constructed from the peripheral blood lymphocytes of two melanoma patients who had been immunized with autologous melanoma cells transduced the gamma-interferon gene to enhance immunogenicity, in a trial conducted at another institution. Anti-melanoma antibodies were selected from each library by panning the phage against live cultures of the autologous tumor. After two or three rounds of panning, clones of the phage were tested by ELISA for binding to the autologous tumor cells; > 90% of the clones tested showed a strong ELISA reaction, demonstrating the effectiveness of the panning procedure for selecting antimelanoma antibodies. The panned phage population was extensively absorbed against normal melanocytes to enrich for antibodies that react with melanoma cells but not with melanocytes. The unabsorbed phage were cloned, and the specificities of the expressed antibodies were individually tested by ELISA with a panel of cultured human cells. The first tests were done with normal endothelial and fibroblast cells to identify antibodies that do not react, or react weakly, with two normal cell types, indicating some degree of specificity for melanoma cells. The proportion of phage clones expressing such antibodies was approximately 1%. Those phage were further tested by ELISA with melanocytes, several melanoma lines, and eight other tumor lines, including a glioma line derived from glial cells that share a common lineage with melanocytes. The ELISA tests identified three classes of anti-melanoma antibodies, as follows: (i) a melanoma-specific class that reacts almost exclusively with the melanoma lines; (ii) a tumor-specific class that reacts with melanoma and other tumor lines but does not react with the normal melanocyte, endothelial and fibroblast cells; and (iii) a lineage-specific class that reacts with the melanoma lines, melanocytes, and the glioma line but does not react with the other lines. These are rare classes from the immunized patients' repertoires of anti-melanoma antibodies, most of which are relatively nonspecific anti-self antibodies. The melanoma-specific class was isolated from one patient, and the lineage-specific class was isolated from the other patient, indicating that different patients can have markedly different responses to the same immunization protocol. The procedures described here can be used to screen the antibody repertoire of any person with cancer, providing access to an enormous untapped pool of human monoclonal anti-tumor antibodies with clinical and research potential.
Resumo:
After ingestion of a standardized dose of ethanol, alcohol concentrations were assessed, over 3.5 hours from blood (six readings) and breath (10 readings) in a sample of 412 MZ and DZ twins who took part in an Alcohol Challenge Twin Study (ACTS). Nearly all participants were subsequently genotyped on two polymorphic SNPs in the ADH1B and ADH1C loci known to affect in vitro ADH activity. In the DZ pairs, 14 microsatellite markers covering a 20.5 cM region on chromosome 4 that includes the ADH gene family were assessed, Variation in the timed series of autocorrelated blood and breath alcohol readings was studied using a bivariate simplex design. The contribution of a quantitative trait locus (QTL) or QTL's linked to the ADH region was estimated via a mixture of likelihoods weighted by identity-by-descent probabilities. The effects of allelic substitution at the ADH1B and ADH1C loci were estimated in the means part of the model simultaneously with the effects sex and age. There was a major contribution to variance in alcohol metabolism due to a QTL which accounted for about 64% of the additive genetic covariation common to both blood and breath alcohol readings at the first time point. No effects of the ADH1B*47His or ADH1C*349Ile alleles on in vivo metabolism were observed, although these have been shown to have major effects in vitro. This implies that there is a major determinant of variation for in vivo alcohol metabolism in the ADH region that is not accounted for by these polymorphisms. Earlier analyses of these data suggested that alcohol metabolism is related to drinking behavior and imply that this QTL may be protective against alcohol dependence.
Resumo:
Developmental- and tissue-specific expression of globin genes is mediated by a few key elements within the proximal promoter of each gene. DNA-binding assays previously identified NF-Y, GATA-1, C/EBP beta and C/EBP gamma as candidate regulators of beta-globin transcription via the CCAAT-box, a promoter element situated between CACC- and TATA-boxes. We have identified C/EBP delta as an additional beta-globin CCAAT-box binding protein. In reporter assays, we show that C/EBP delta can co-operate with EKLF, a CACC-box binding protein, to activate the beta-globin promoter, whereas C/EBP gamma inhibits the transcriptional activity of EKLF in this assay. (c) 2005 Elsevier B.V. All rights reserved.